ArticleCost effectiveness and resource allocation : C/E2022
Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis.
Article in Cost effectiveness and resource allocation : C/E, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Quality of life and stigma among persons affected by leprosy or buruli ulcer in Nigeria: a community-based cross-sectional study.BMC public health · 2025Article
- Participatory development of Indonesia's national action plan for zero leprosy: strategies and interventions.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundThe state of leprosy in Nigeria and the realities of post elimination era underscore the need for evidence- based cost-effective approach to early case detection for enhanced control and elimination of leprosy. This study evaluated the operational cost-effectiveness of a community delivered Legacy Innovative Project implemented to enhance leprosy case detection in northern Nigeria.
methodsData were collected from an explorative cross-sectional study, undertaken in a practice setting among endemic communities in three states in northern Nigeria. Primary and secondary data were collected from the project, routine records and programme annual reports. Costs and effects were measured from both providers' and patients' perspectives, and outcome expressed as cost per new case detected. Incremental estimates of costs and effects of the project compared to routine practice were used to obtain the cost-effectiveness result, as incremental cost-effectiveness ratio (ICER). All costs were converted to the US Dollar at 2018exchange rate (N350 = US$1.00). Univariate sensitivity analysis was performed to evaluate uncertainties around the ICER.
resultsThe Project overall detected a total of 347 newly confirmed leprosy cases at a total annual cost of US$49,337.19, averaging US$142.18 per new case detected. Key cost drivers included routine meetings, which accounted for 28% of total expenditure, while Social Mobilization and Training/Workshop accounted for17% respectively. Findings were similar across the states. Overall, the Project dominated routine practice with ICER of US$(-17.73) per additional/new case detected, as a very cost-effective strategy. Sensitivity analysis reinforced the cost-effectiveness result.
conclusionsThe Legacy Innovative Project demonstrated a more efficient and cost-saving approach to leprosy case detection. Findings present important information to policy and programmes for enhanced control and elimination of leprosy in related settings. .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.